Adalat and Premature delivery - a phase IV clinical study of FDA data

Summary:

Premature delivery is reported as a side effect among people who take Adalat (nifedipine), especially for people who are 30-39 old, have been taking the drug for < 1 month also take Prograf, and have Tocolysis.

The phase IV clinical study analyzes which people have Premature delivery when taking Adalat. It is created by eHealthMe based on reports of 20,643 people who have side effects when taking Adalat from the FDA, and is updated regularly.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

What is Premature delivery?

Premature delivery is found to be associated with 558 drugs and 733 conditions by eHealthMe. Check the latest studies of Premature delivery.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

20,643 people reported to have side effects when taking Adalat.
Among them, 31 people (0.15%) have Premature delivery.

Among these 31 people:

How long have people been on Adalat when they have Premature delivery? *

What is the age of people who have Premature delivery when taking Adalat? *

What are other drugs people take besides Adalat? *

What are other side effects people have besides Premature delivery? *

Maternal Exposure During Pregnancy (use of substance during pregnancy): 16 people, 51.61%
Polyhydramnios (excess of amniotic fluid in the amniotic sac): 11 people, 35.48%
Cervical Incompetence (serious pregnancy complication in which the cervix starts to open): 8 people, 25.81%
Premature Labor: 5 people, 16.13%
Birth Control: 4 people, 12.90%
Foetal Growth Restriction (poor growth of a baby while in the mother's womb during pregnancy): 3 people, 9.68%
White Blood Cell Count Increased: 2 people, 6.45%
Pre-Eclampsia (high blood pressure and significant amounts of protein in the urine of a pregnant woman): 2 people, 6.45%
Drug Ineffective: 1 person, 3.23%
Haemoglobin Decreased: 1 person, 3.23%

What are the existing conditions these people have? *

Maternal Therapy To Enhance Foetal Lung Maturity: 10 people, 32.26%
Tocolysis (inhibition of uterine contractions): 10 people, 32.26%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 29.03%
Renovascular Hypertension (a syndrome which consists of high blood pressure caused by the kidneys hormonal response): 9 people, 29.03%
Type 2 Diabetes: 3 people, 9.68%
Gingival Hypertrophy (overgrowth of gums): 3 people, 9.68%
Foetal Growth Restriction (poor growth of a baby while in the mother's womb during pregnancy): 3 people, 9.68%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 6.45%
Gestational Hypertension (elevated blood pressure during pregnancy): 1 person, 3.23%
Gestational Diabetes (diabetes in pregnancy): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat and have Premature delivery?

- Check whether Premature delivery is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adalat:

Adalat (20,940 reports)

Browse all side effects of Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Premature delivery:

Premature delivery (558 drugs)

Browse all the conditions that are associated with Premature delivery:

Premature delivery (733 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Adalat) and Adalat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.